MTP hit with new suspension order as Medway problems linger
This article was originally published in Scrip
Executive Summary
Japan's ministry of health, labour and welfare has issued new administrative actions against Mitsubishi Tanabe Pharma (MTP) and its Bipha manufacturing subsidiary, marking the latest in a years-long string of regulatory transgressions at MTP.